Case Reports
August 19, 2015
Vol. 79 No. 3-4 (2013): Pulmonary series - Supplement 1
https://doi.org/10.4081/monaldi.2013.29

Two cases of COPD benefitting from therapy with roflumilast

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Roflumilast, COPD, Case report, Hypoxemia, Bronchitis
844
Views
683
Downloads

Authors

Chiara Francesca Carraro
ch_carraro@libero.it
Pneumology Clinic, ASL TO4, Civil Hospital of Chivasso (TO), Italy.
Two clinical cases of chronic obstructive pulmonary disease (COPD) stage II patients are reported here. One case refers to a patient with hypoxemia associated to severe air flow limitation, chronic bronchitis and frequent exacerbation events. A significant improvement of patient’s conditions was observed after pharmacological treatment with roflumilast. The second case refers to a patient who refused to adhere to prescribed therapy but adhered to roflumilast therapy, eventually achieving a good response. Both cases highlight roflumilast’s efficacy in improving health conditions of COPD patients.

Altmetrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite



“Two Cases of COPD Benefitting from Therapy With Roflumilast”. 2015. Monaldi Archives for Chest Disease 79 (3-4). https://doi.org/10.4081/monaldi.2013.29.